Document Type : Original Article

Authors

1 Molecular and Medicine Research Center, Khomein University of Medical Sciences, Khomein, Iran

2 Department of Operating Room and Anesthesiology, Khomein University of Medical Sciences, Khomein, Iran

3 Clinical Research Development Center of Amirkabir Hospital, Arak University of Medical Sciences, Arak, Iran

4 Department of Pediatrics, Amirkabir Hospital, Arak University of Medical Sciences, Arak, Iran

Abstract

Background: Pulmonary arterial hypertension (PAH) is an uncommon syndrome characterized by dyspnea and fatigue resulting from a progressive elevation in pulmonary vascular resistance. Recent research suggests that the relationship between pulmonary arterioles and platelets could be connected to the ongoing changes in pulmonary blood vessels seen in PAH. Therefore, this study aimed to assess platelet indices in pediatric patients with PAH.
Methods: This study in pediatric cardiology was conducted in 2020. Laboratory and clinical data were obtained retrospectively from hospital records. All patients had undergone physical examination and echocardiography. The study included 44 pediatric cases with congenital heart disease (CHD).
Results: Mean and standard deviation (SD) of age in cases with and without PAH were 7.75±3.64 and 5.97±3.71, respectively; the male/female ratio in the two groups was 10:12. The mean and SD of pulmonary artery pressure (PAP) in cases with and without PAH were 36.81±6.08 and 19.80±2.78 mm Hg ; also, right ventricular systolic diameter (RVSD) and right ventricular diastolic diameter (RVDD) did not show a statistically significant difference in echocardiography. Hemoglobin (Hb) (P=0.146), hematocrit (HCT) (P=0.712), and platelet count did not show statistically significant differences. However, mean platelet volume (MPV), Platelet distribution width (PDW), and plateletcrit (PCT) in PAH cases were significantly higher than cases with normal pulmonary tension (P=0.0001). Also, our study showed a correlation between MPV, PCT, PDW, and PAH.
Conclusion: Our study demonstrated a notable elevation in MPV and PDW among pediatric patients with PAH and identified a relationship between PDW and MPV in this patient population.

Keywords

Main Subjects

  1. Naeije R, Richter MJ, Rubin LJ. The physiological basis of pulmonary arterial hypertension. Eur Respir J. 2022;59(6):2102334. doi: 10.1183/13993003.02334-2021.
  1. Hella E, El Amrousy D, El-Serogy H, Zoair A. Diagnostic and predictive values of plasma connective tissue growth factor in children with pulmonary hypertension associated with CHD. Cardiol Young. 2020;30(4):533-8. doi: 10.1017/ s104795112000058x.
  2. Hanson SJ, Karam O, Birch R, Goel R, Patel RM, Sola-Visner M, et al. Transfusion practices in pediatric cardiac surgery requiring cardiopulmonary bypass: a secondary analysis of a clinical database. Pediatr Crit Care Med. 2021;22(11):978-87. doi: 10.1097/pcc.0000000000002805.
  3. Mese T, Guven B, Yilmazer MM, Karadeniz C, Ozdemir R, Doksoz O. Platelet activation markers in children with congenital heart disease associated with pulmonary arterial hypertension. Congenit Heart Dis. 2018;13(4):506-11. doi: 10.1111/chd.12616.
  4. Gu L, Li YY, Gu L, Xie L, Liu HM. Idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease in Chinese children: similarities, differences, and prognostic factors. Front Pediatr. 2020;8:106. doi: 10.3389/fped.2020.00106.
  5. Dieu A, Van Regemorter V, Detaille T, Houtekie L, Eeckhoudt S, Khalifa C, et al. Combined use of rotational thromboelastometry (ROTEM) and platelet impedance aggregometry (Multiplate® analyzer) in cyanotic and acyanotic infants and children undergoing cardiac surgery with cardiopulmonary bypass: subgroup analysis of a randomized clinical trial. J Cardiothorac Vasc Anesth. 2021;35(7):2115-23. doi: 10.1053/j.jvca.2020.09.133.
  6. Di Gregorio G, Sella N, Spiezia L, Menin E, Boscolo A, Pasin L, et al. Cardiopulmonary bypass-induced coagulopathy in pediatric patients: the role of platelets in postoperative bleeding. A preliminary study. Artif Organs. 2021;45(8):852- 60. doi: 10.1111/aor.13912.
  7. Berger G, Azzam ZS, Hoffman R, Yigla M. Coagulation and anticoagulation in pulmonary arterial hypertension. Isr Med Assoc J. 2009;11(6):376-9.
  8. El Amrousy D, Zahran E, El-Serogy H, Zoair A. Plasma growth differentiation factor-15 in children with pulmonary hypertension associated with congenital heart disease: a canary in the mine? Prog Pediatr Cardiol. 2020;59:101206. doi: 10.1016/j.ppedcard.2020.101206.
  9. Barker EE, Saini A, Gazit AZ, Shea SM, Baltagi S, Gage BF, et al. TEG platelet mapping and impedance aggregometry to predict platelet transfusion during cardiopulmonary bypass in pediatric patients. Front Pediatr. 2019;7:509. doi: 10.3389/ fped.2019.00509.
  10. Zheng YG, Yang T, Xiong CM, He JG, Liu ZH, Gu Q, et al. Platelet distribution width and mean platelet volume in idiopathic pulmonary arterial hypertension. Heart Lung Circ. 2015;24(6):566-72. doi: 10.1016/j.hlc.2014.11.025.
  11. Mandalenakis Z, Giang KW, Eriksson P, Liden H, Synnergren M, Wåhlander H, et al. Survival in children with congenital heart disease: have we reached a peak at 97%? J Am Heart Assoc. 2020;9(22):e017704. doi: 10.1161/jaha.120.017704.
  12. Arslan D, Cimen D, Guvenc O, Kaya F, Sert A, Oran B. Platelet distribution width and mean platelet volume in children with pulmonary arterial hypertension secondary to congenital heart disease with left-to-right shunt: new indices of severity? Pediatr Cardiol. 2013;34(4):1013-6. doi: 10.1007/s00246- 012-0600-5.
  13. Varol E, Uysal BA, Ozaydin M. Platelet indices in patients with pulmonary arterial hypertension. Clin Appl Thromb Hemost. 2011;17(6):E171-4. doi: 10.1177/1076029610394438.
  14. Lannan KL, Phipps RP, White RJ. Thrombosis, platelets, microparticles and PAH: more than a clot. Drug Discov Today. 2014;19(8):1230-5. doi: 10.1016/j.drudis.2014.04.001.
  15. Vizioli L, Muscari S, Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract. 2009;63(10):1509-15. doi: 10.1111/j.1742-1241.2009.02070.x.
  16. Zheng YY, Wang L, Shi Q. Mean platelet volume (MPV) and platelet distribution width (PDW) predict clinical outcome of acute ischemic stroke: a systematic review and metaanalysis. J Clin Neurosci. 2022;101:221-7. doi: 10.1016/j. jocn.2022.05.019.
  17. Thiraviam M, Sunderesh Kamal Chander U, Muthuvel E. A correlative study of MPV, PDW and plateletcrit in patients with hyperthyroidism, hypothyroidism and euthyroid in tertiary care centre. Saudi J Pathol Microbiol. 2021;6(10):369-74. doi: 10.36348/sjpm.2021.v06i10.008.
  18. Can MM, Tanboğa IH, Demircan HC, Ozkan A, Koca F, Keleş N, et al. Enhanced hemostatic indices in patients with pulmonary arterial hypertension: an observational study. Thromb Res. 2010;126(4):280-2. doi: 10.1016/j.thromres.2010.06.020.
  19. Yazici S, Yazici M, Erer B, Erer B, Calik Y, Ozhan H, et al. The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets. 2010;21(2):122-5. doi: 10.3109/09537100903474373.
  20. Liu R, Gao F, Huo J, Yi Q. Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease. Platelets. 2012;23(1):11-6. doi: 10.3109/09537104.2011.586073.